Tecentriq gets FDA Priority Review for colon cancer stage 3
Tecentriq receives FDA Priority Review for stage 3 colon cancer treatment, offering new hope for patients with dMMR/MSI-H tumors.
Tag
Health News. Zero Fluff.
Tag
Tecentriq receives FDA Priority Review for stage 3 colon cancer treatment, offering new hope for patients with dMMR/MSI-H tumors.